News

Lassila & Tikanoja: A New Breed in Circular Economy Services

Lassila & Tikanoja: A New Breed in Circular Economy Services

Lassila & Tikanoja: A New Dawn After the Demerger

Lassila & Tikanoja plc has made significant strides in its journey towards becoming a leader in the circular economy sector. With their recent announcement concerning a demerger, they are set to enhance their market presence and operational efficiency. As the Finnish Financial Supervisory Authority approves the demerger and related listing prospectus, the company prepares to present a new operational face to the market.

The Demerger and Its Significance

The demerger, officially recognized on November 20, 2025, signifies a notable shift in Lassila & Tikanoja’s operational structure. This strategic move involves transferring all assets and liabilities specifically related to the circular economy business to a newly formed entity, officially titled New Lassila & Tikanoja. This new company will officially begin trading on the Nasdaq Helsinki exchange on January 2, 2026, marking a new era for the business.

As part of this transition, the parent company will be rebranded as Luotea Plc, retaining its existing Facility Services business area. This change is expected to allow both entities to focus more effectively on their respective core competencies—Lassila & Tikanoja on circular economy services and Luotea on facility management.

Leadership Structure at the New Lassila & Tikanoja

In preparation for the change, the Board of Directors has proposed key appointments for leadership positions within the New Lassila & Tikanoja. Eero Hautaniemi will take on the role of President and CEO, while Joni Sorsanen is proposed as the CFO. Their leadership is crucial as the company navigates its new structure and aims to achieve its ambitious goals in the circular economy sector.

Management Team Overview

The management team at New Lassila & Tikanoja will also include notable figures such as:

  • Antti Tervo as Senior Vice President of Growth and Operations
  • Juha Saarinen as Chief Purchasing Officer
  • Hilppa Rautpalo as Senior Vice President of Legal, HR, and EHSQ
  • Jorma Mikkonen as Senior Vice President of Corporate Relations and Sustainability
  • Edward Skärström as Chief Information Officer

This robust management lineup will guide the company's strategy in the rapidly changing landscape of circular economy solutions.

Financial Objectives and Strategies

The Board has laid out ambitious financial targets for the New Lassila & Tikanoja aiming for an annual net sales growth exceeding 6% in the mid-term, while maintaining an adjusted EBITA margin of 11%. Their focus on sustainability and circular economy practices positions them well in a market increasingly defined by environmental consciousness.

Key focus areas include:

  • Core Business Development: Expanding the service network and improving service offerings to deepen customer relationships.
  • Valorisation of Waste: Enhancing material value through innovative recycling processes.
  • Expansion in Sweden: Targeting acquisitions and growth to build a strong foothold in Swedish markets.

Market Demand and Competitive Edge

The market for circular economy services is expanding, propelled by regulatory pressures and a societal push towards sustainability. New Lassila & Tikanoja is well-positioned to respond to these demands, leveraging their existing infrastructure and customer base of approximately 22,000 corporate clients.

The company’s extensive network and operational sophistication provide it with a significant competitive edge, especially as it aims to capitalize on advancing recycling technologies and the demand for sustainable waste management solutions.

Exploring Financial Strengths

The financial outlook for New Lassila & Tikanoja looks promising with stable performance, demonstrated by an adjusted EBITA margin consistently around 10% from 2022 to 2024. This strength not only underscores the organization’s operational efficiency but also its commitment to maintaining a strong balance sheet.

Conclusion: Looking Ahead

As New Lassila & Tikanoja transitions into this new phase, it aims to redefine its role in the circular economy sector. The strategic demerger and the establishment of Luotea Plc are expected to enhance operational focus and facilitate better resource allocation.

For more information about the New Lassila & Tikanoja, potential investors and stakeholders are encouraged to explore the detailed financial information available in the Prospectus.

Frequently Asked Questions

What is the purpose of the demerger for Lassila & Tikanoja?

The demerger aims to create a focused entity specialized in circular economy services, allowing each company to optimize operations and better serve their respective markets.

Who are the key members of the management team for the New Lassila & Tikanoja?

The management team includes Eero Hautaniemi as President and CEO and Joni Sorsanen as CFO, along with several other senior leaders in various operational areas.

What are the financial targets set for the New Lassila & Tikanoja?

The company aims for an annual net sales growth of over 6% and an adjusted EBITA margin of 11% in the mid-term.

How does the circular economy influence business strategy?

The circular economy is central to the company’s strategy, as it embraces sustainable practices while seeking to innovate in waste valorization and recycling technologies.

When will trading for the New Lassila & Tikanoja begin?

Trading for New Lassila & Tikanoja is expected to start on January 2, 2026, on the Nasdaq Helsinki exchange.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 141

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 303

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 143

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading

Top 5 Most Recently Viewed Articles

Heights Wellness Retreat: A Bold Step Towards Holistic Wellness

Updated Category News Views 227

Heights Wellness Retreat: A New Era of Wellness In a landmark announcement during their annual summit, Massage Heights unveiled a significant transformation that redefines their brand identity. The brand, known for its commitment to wellness over the past two decades, will now operate under the name Heights Wellness Retreat. This evolution is more than just a new name; it...

Continue Reading
GeneDx Strengthens Leadership with New COO Appointment

Updated Category News Views 168

GeneDx Welcomes Bryan Dechairo as Chief Operating Officer GeneDx (NASDAQ: WGS) has made headlines with the appointment of Bryan Dechairo as its new Chief Operating Officer. This strategic decision aims to enhance operations and drive the company’s next phase of growth. Enhancing Operations for Future Success As COO, Dechairo will oversee critical areas including Product...

Continue Reading
FreightCar America to Share Q1 2025 Financial Results Soon

Updated Category News Views 130

FreightCar America Prepares for Q1 2025 Earnings Announcement FreightCar America, Inc. (NASDAQ: RAIL), a prominent player in the manufacturing of railroad freight cars, is gearing up to release its financial results for the first quarter of 2025. This important announcement is scheduled for after the market closes on a Monday, allowing investors and stakeholders to digest...

Continue Reading
Empowering Veterans: United Food Group's New Initiative

Updated Category News Views 129

United Food Group Unveils New Employment Initiative United Food Group, a noted developer and manufacturer of coffee equipment, powdered condiments, and beverages, has announced an innovative employment initiative designed to support wounded veterans and first responders. This program not only aims to empower these individuals but also provides them with specialized...

Continue Reading
US Futures Gain on Peace Talk Hopes Amid Market Developments

Updated Category News Views 206

U.S. Stock Futures Trend Upward U.S. stock futures saw an increase following the extended weekend, coming off a mixed trading day last Friday. The day off for Presidents Day allowed investors to reassess their positions. As a result, all four major indices posted gains in premarket trading. Investor Focus on Macro Conditions In today's trading, investors will closely...

Continue Reading